Acurx Pharmaceuticals (ACXP) Cash & Equivalents (2020 - 2026)
Acurx Pharmaceuticals (ACXP) recorded Cash & Equivalents of $10.7 million in Q2 2026, up 76.4% from $6.06 million a year earlier and up 15.1% from the prior quarter.
Powered by 
Analysis
Acurx Pharmaceuticals (ACXP) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Acurx Pharmaceuticals reported Cash & Equivalents of $7.56 million, up 103.8% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $3.71 million in FY2024 (-50.4%), $7.47 million in FY2023 (-18.0%), $9.11 million in FY2022 (-29.7%) and $12.96 million in FY2021 (+308.1%).
- The Q2 2026 figure is the highest quarterly Cash & Equivalents since Q1 2022.
- On a year-over-year basis, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 20.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 324.4% in Q3 2021, against a decline of 50.4% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.3 million (Q1 2026), $7.56 million (Q4 2025) and $5.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Acurx Pharmaceuticals | 4.86 Mn | -28.61 Mn | - | 10.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.70 Mn |
| Mar 31, 2026 | 9.30 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | 5.91 Mn |
| Jun 30, 2025 | 6.06 Mn |
| Mar 31, 2025 | 4.64 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 5.76 Mn |
| Jun 30, 2024 | 6.36 Mn |
| Mar 31, 2024 | 8.92 Mn |
| Dec 31, 2023 | 7.47 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Jun 30, 2023 | 9.15 Mn |
| Mar 31, 2023 | 7.18 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Sep 30, 2022 | 10.61 Mn |
| Jun 30, 2022 | 9.09 Mn |
| Mar 31, 2022 | 11.08 Mn |
| Dec 31, 2021 | 12.96 Mn |
| Sep 30, 2021 | 14.46 Mn |
API Access
Acurx Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ACXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();